{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:30:38Z","timestamp":1787772638996,"version":"build-2784847793"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is a highly prevalent endocrine disorder among females of fertile age. It has been speculated to be associated with low-grade chronic inflammation like other inflammatory response-driven multifactorial illnesses such as diabetes mellitus (DM) and cancer. Monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) are biomarkers of inflammation and endothelial dysfunction, respectively. These have been found to be elevated in PCOS patients. The current research reveals that single nucleotide polymorphisms (SNPs) in their genes are strongly associated with the elevation of these biomarkers. The goal of this study was to see if there was a link between PAI-1 -675 4G\/5G and MCP-1 -2518 A\/G polymorphisms with the occurrence of PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Method:<\/jats:title>\n                    <jats:p>This study included 220 PCOS participants and 220 healthy controls. The allele-specific polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods were used to investigate PAI-1-675 4G\/5G and MCP-1 -2518A\/G SNPs, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The -675 4G\/5G SNP in the PAI-1 gene was strongly linked to PCOS. The odds ratio (OR) for the 4G\/4G genotype was (OR = 3.2;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), whereas the OR for the 4G\/5G genotype was (OR = 2.39;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). The carriers with the 4G\/4G and 4G\/5G genotypes showed significantly increasing trends in the triglyceride levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). The genotypic frequency of the -2518 A\/G MCP-1 SNP differed significantly between the PCOS patients and healthy controls; the GG genotype remained a strong predictor of PCOS (OR = 8.7;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01) and the AG genotype (OR = 2.40;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01), indicating an elevated risk of predisposing women to PCOS. There was a significant variation in the glucose 2-h levels between -2518A\/G MCP-1 genotypes with AG heterozygous and GG mutant genotype showing increasing trends of glucose 2-h levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Both PAI-1 -675 4G\/5G and MCP-1 -2518A\/G polymorphisms are associated with predisposition to PCOS and its complications in Kashmiri women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1916_21","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T06:27:00Z","timestamp":1663050420000},"page":"4743-4752","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association of -675 4G\/5G PAI-1 and -2518A\/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study"],"prefix":"10.4103","volume":"11","author":[{"given":"Syed Douhath","family":"Yousuf","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ashraf","family":"Ganie","sequence":"additional","affiliation":[{"name":"Department of Endocinology, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Mudassar","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humiara","family":"Shafi","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, University of Kashmir, Jammu and Kashmir, India"},{"name":"Humaira shafi and Saima ibrahim contributed equally"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, University of Kashmir, Jammu and Kashmir, India"},{"name":"Humaira shafi and Saima ibrahim contributed equally"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humira","family":"Jeelani","sequence":"additional","affiliation":[{"name":"Advanced Centre for Human Genetics, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowhar","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Zargar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Nuner Campus, Central University of Kashmir, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, University of Kashmir, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"B1-20240828","first-page":"19","volume":"81","year":"2004","journal-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijgo.13125","article-title":"Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study","volume":"149","author":"Ganie","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/jhrs.JHRS_78_17","article-title":"Possible link between stress-related factors and altered body composition in women with polycystic ovarian syndrome","volume":"11","author":"Basu","year":"2018","journal-title":"J Hum Reprod Sci"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome","volume":"96","author":"Manneras-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcp.29912","article-title":"Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome","volume":"236","author":"Rostamtabar","year":"2021","journal-title":"J Cell Physiol"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1038\/s41598-021-84586-y","article-title":"Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome","volume":"11","author":"Moin","year":"2021","journal-title":"Sci Rep"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S1462399408000598","article-title":"Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications","volume":"10","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1210\/jcem.87.8.8715","article-title":"Comment: The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism","volume":"87","author":"Peral","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B11-20240828","first-page":"1134","article-title":"The -597 G - and -174 G - C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism","volume":"87","author":"Villuendas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/oby.2003.136","article-title":"Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism","volume":"11","author":"Escobar-Morreale","year":"2003","journal-title":"Obes Res"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.51.467","article-title":"The plasminogen activator system in young and lean women with polycystic ovary syndrome","volume":"51","author":"Tarkun","year":"2004","journal-title":"Endocr J"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/ATVBAHA.107.149468","article-title":"Association of plasminogen activator inhibitor (PAI)-1(SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: The HIFMECH study","volume":"27","author":"Morange","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2222.2009.03272.x","article-title":"Plasminogen activator inhibitor-1 and asthma: Role in the pathogenesis and molecular regulation","volume":"39","author":"Ma","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/gtmb.2009.0039","article-title":"Association of PAI-1 4G\/5G and -844G\/A gene polymorphisms and changes in PAI-1\/tissue plasminogen activator levels in myocardial infarction: A case-control study","volume":"14","author":"Abboud","year":"2010","journal-title":"Genet Test Mol Biomarkers"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterrale","year":"2020","journal-title":"Front Physiol"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2174\/0929867327666200824112056","article-title":"Obesity and insulin resistance: Associations with chronic inflammation, genetic and epigenetic factors","volume":"28","author":"Gasmi","year":"2021","journal-title":"Curr Med Chem"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B24-20240828","first-page":"5076858","article-title":"Elevated serum TNF-a is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance","volume":"2020","author":"Alzamil","year":"2020","journal-title":"J Obese"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cells10051197","article-title":"Inflammation and atherosclerosis","volume":"10","author":"Ley","year":"2021","journal-title":"Cells"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1111\/aji.13407","article-title":"Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis","volume":"86","author":"Wu","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"B27-20240828","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/ajpendo.00213.2021","article-title":"Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome","volume":"321","author":"Gonzalez","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B28-20240828","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db11-1508","article-title":"Adipose tissue microRNAs as regulators of CCL2 production in human obesity","volume":"61","author":"Arner","year":"2012","journal-title":"Diabetes"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20080581","article-title":"Role of MCP-1 in cardiovascular disease: Molecular mechanisms and clinical implications","volume":"117","author":"Niu","year":"2009","journal-title":"Clin Sci Lond"},{"key":"B30-20240828","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s10067-016-3380-0","article-title":"The -2518 A\/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients","volume":"35","author":"Martin","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B31-20240828","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2016.07.016","article-title":"Association of monocyte chemo attractant protein-1 gene 2518A\/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis","volume":"120","author":"Wang","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"B32-20240828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60327-411-1_1","article-title":"SNPs: Impact on gene function and phenotype","volume":"578","author":"Shastry","year":"2009","journal-title":"Methods Mol Biol"},{"key":"B33-20240828","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/eje.0.1500793","article-title":"The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1(PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels","volume":"150","author":"Diamanti-Kandarakis","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B34-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/molehr\/gan072","article-title":"Plasminogen activator inhibitor-1 4G\/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome","volume":"15","author":"Bagos","year":"2009","journal-title":"Mol Hum Repro"},{"key":"B35-20240828","doi-asserted-by":"crossref","first-page":"149","DOI":"10.6026\/97320630013149","article-title":"Polymorphism of the PAI-1gene (4G\/5G) may be linked with polycystic ovary syndrome and associated pregnancy disorders in South Indian women","volume":"13","author":"Mary","year":"2017","journal-title":"Bioinformation"},{"key":"B36-20240828","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.metabol.2003.06.001","article-title":"Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: Associations with recurrent pregnancy loss","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"B37-20240828","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B38-20240828","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1055\/s-0037-1614340","article-title":"The 4G\/4G genotype of the plasminogen activator inhibitor 4G\/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease","volume":"82","author":"Gardemann","year":"1999","journal-title":"Thromb Haemost"},{"key":"B39-20240828","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0037-1614516","article-title":"Plasminogen activator inhibitor-1 (PAI-1) promoter 4G\/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease","volume":"81","author":"Grancha","year":"1999","journal-title":"Thromb Haemost"},{"key":"B40-20240828","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.metabol.2005.09.008","article-title":"Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome","volume":"55","author":"Glueck","year":"2006","journal-title":"Metabolism"},{"key":"B41-20240828","first-page":"0123045","article-title":"Genetic variation in the MCP-1 gene promoter associated with the risk of polycystic ovary syndrome","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"B42-20240828","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1097\/01.ASN.0000031701.53792.54","article-title":"A Monocyte chemoattractant protein-1(MCP-1) polymorphism and outcome after renal transplantation","volume":"13","author":"Kruger","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B43-20240828","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12020-010-9342-4","article-title":"Monocyte chemoattractant protein-1 (MCP-1) 2518G\/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy","volume":"37","author":"Karadeniz","year":"2010","journal-title":"Endocrine"},{"key":"B44-20240828","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MBC.0b013e328340126c","article-title":"Association between the monocyte chemoattractant protein-1 -2518G\/A gene polymorphism and acute myocardial infarction patients among Egyptian population","volume":"22","author":"EL Mahgoub","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B45-20240828","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1007\/s11033-012-1773-y","article-title":"Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility","volume":"39","author":"Lin","year":"2012","journal-title":"Mol Biol Rep"},{"key":"B46-20240828","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2011.07.116","article-title":"Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: A meta-analysis","volume":"219","author":"Wang","year":"2011","journal-title":"Atherosclerosis"},{"key":"B47-20240828","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOL.0b013e32833b7782","article-title":"Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance","volume":"2","author":"Savage","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"B48-20240828","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12958-018-0336-z","article-title":"Obesity as disruptor of the female fertility","volume":"16","author":"Erica Silvestris","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"B49-20240828","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11515-018-1500-8","article-title":"The effect of coagulation factors polymorphisms on abortion","volume":"3","author":"Feizollahi","year":"2018","journal-title":"Front Biol"},{"key":"B50-20240828","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpag.2016.06.010","article-title":"Does the oral contraceptive pill increase plasma intercellular adhesion molecule-1, monocyte chemoattractant protein-1, and tumor necrosis factor-a levels in women with polycystic ovary syndrome: A pilot study","volume":"30","author":"Yousuf","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"B51-20240828","first-page":"151","article-title":"Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 and factor VIII among women with polycystic ovary syndrome: An observational pilot study","volume":"148","author":"Yousuf","year":"2018","journal-title":"Indian J Med Res"},{"key":"B52-20240828","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1038\/s41598-019-46644-4","article-title":"Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with polycystic ovarian syndrome: An observational study","volume":"9","author":"Manzoor","year":"2019","journal-title":"Sci Rep"},{"key":"B53-20240828","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12291-020-00901-w","article-title":"Analysis of intrinsic and extrinsic coagulation pathway factors in OCP treated PCOS women","volume":"36","author":"Manzoor","year":"2021","journal-title":"Indian J Clin Biochem"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1916_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:06:59Z","timestamp":1787771219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1916_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1916_21","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"2021-09-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}